

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.65165577 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.65165577 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.29193560 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.29193560 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.88144921 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.46558025 |
| 7 | tryptophan catabolic process (GO:0006569) | 6.20471125 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.20471125 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.20471125 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.04741346 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.85141581 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.80678812 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.70444437 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.69704247 |
| 15 | urea cycle (GO:0000050) | 5.68452508 |
| 16 | urea metabolic process (GO:0019627) | 5.68452508 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.56610939 |
| 18 | alpha-linolenic acid metabolic process (GO:0036109) | 5.45967299 |
| 19 | cysteine metabolic process (GO:0006534) | 5.40310027 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.34143171 |
| 21 | protein carboxylation (GO:0018214) | 5.32515557 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.32515557 |
| 23 | sulfur amino acid catabolic process (GO:0000098) | 5.25526304 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.22438456 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.14575558 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.12313397 |
| 27 | serine family amino acid catabolic process (GO:0009071) | 5.04307299 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 5.01200076 |
| 29 | aromatic amino acid family metabolic process (GO:0009072) | 4.98827138 |
| 30 | bile acid metabolic process (GO:0008206) | 4.97898447 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.97093693 |
| 32 | regulation of cholesterol esterification (GO:0010872) | 4.95694381 |
| 33 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.82982871 |
| 34 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.82489684 |
| 35 | cellular extravasation (GO:0045123) | 4.81888629 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.81268553 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.81268553 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.81268553 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.80613651 |
| 40 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.78272942 |
| 41 | regulation of complement activation (GO:0030449) | 4.77705056 |
| 42 | phospholipid efflux (GO:0033700) | 4.77200912 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 4.74094549 |
| 44 | negative regulation of sterol transport (GO:0032372) | 4.74094549 |
| 45 | negative regulation of cell killing (GO:0031342) | 4.73843839 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.73843839 |
| 47 | lysine metabolic process (GO:0006553) | 4.64148632 |
| 48 | lysine catabolic process (GO:0006554) | 4.64148632 |
| 49 | homocysteine metabolic process (GO:0050667) | 4.64105121 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.62745312 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.62745312 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.60728648 |
| 53 | amino-acid betaine metabolic process (GO:0006577) | 4.48410027 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 4.43983064 |
| 55 | bile acid and bile salt transport (GO:0015721) | 4.41451181 |
| 56 | coenzyme catabolic process (GO:0009109) | 4.41269192 |
| 57 | drug catabolic process (GO:0042737) | 4.41195548 |
| 58 | glycine metabolic process (GO:0006544) | 4.36716697 |
| 59 | modulation by symbiont of host defense response (GO:0052031) | 4.36205289 |
| 60 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.36205289 |
| 61 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.36205289 |
| 62 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.36205289 |
| 63 | modulation by symbiont of host immune response (GO:0052553) | 4.36205289 |
| 64 | positive regulation by symbiont of host defense response (GO:0052509) | 4.36205289 |
| 65 | cholesterol efflux (GO:0033344) | 4.35574326 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 4.35396090 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.32870962 |
| 68 | amine catabolic process (GO:0009310) | 4.32870962 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.31443923 |
| 70 | neutrophil activation involved in immune response (GO:0002283) | 4.30043168 |
| 71 | detection of bacterium (GO:0016045) | 4.29770682 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 4.28844550 |
| 73 | glutamate metabolic process (GO:0006536) | 4.28185427 |
| 74 | epoxygenase P450 pathway (GO:0019373) | 4.25459477 |
| 75 | detection of other organism (GO:0098543) | 4.23792550 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 4.22661731 |
| 77 | plasma lipoprotein particle assembly (GO:0034377) | 4.21921574 |
| 78 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.17026438 |
| 79 | serine family amino acid metabolic process (GO:0009069) | 4.16299781 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.15338150 |
| 81 | cellular glucuronidation (GO:0052695) | 4.14895115 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 4.11698430 |
| 83 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.06736728 |
| 84 | response to peptidoglycan (GO:0032494) | 4.05792500 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.04492882 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.04492882 |
| 87 | ethanol oxidation (GO:0006069) | 4.03462739 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 4.03441796 |
| 89 | arginine metabolic process (GO:0006525) | 4.03337682 |
| 90 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00955494 |
| 91 | serine family amino acid biosynthetic process (GO:0009070) | 3.99133360 |
| 92 | exogenous drug catabolic process (GO:0042738) | 3.93474908 |
| 93 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.89919042 |
| 94 | fibrinolysis (GO:0042730) | 3.89749920 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 3.85851042 |
| 96 | macrophage activation involved in immune response (GO:0002281) | 3.85281017 |
| 97 | cofactor catabolic process (GO:0051187) | 3.83853180 |
| 98 | blood coagulation, intrinsic pathway (GO:0007597) | 3.83628382 |
| 99 | aldehyde catabolic process (GO:0046185) | 3.83292130 |
| 100 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.80397654 |
| 101 | protein-lipid complex assembly (GO:0065005) | 3.78464598 |
| 102 | flavonoid metabolic process (GO:0009812) | 3.78200029 |
| 103 | cholesterol homeostasis (GO:0042632) | 3.77095486 |
| 104 | positive regulation of lipid catabolic process (GO:0050996) | 3.76392391 |
| 105 | plasma lipoprotein particle organization (GO:0071827) | 3.73961118 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 3.73830756 |
| 107 | negative regulation of lipase activity (GO:0060192) | 3.73661201 |
| 108 | complement activation, classical pathway (GO:0006958) | 3.72591431 |
| 109 | phospholipid homeostasis (GO:0055091) | 3.71990668 |
| 110 | regulation of gamma-delta T cell activation (GO:0046643) | 3.71507638 |
| 111 | sterol homeostasis (GO:0055092) | 3.70516456 |
| 112 | ketone body metabolic process (GO:1902224) | 3.69978670 |
| 113 | regulation of bile acid biosynthetic process (GO:0070857) | 3.68498269 |
| 114 | leukocyte aggregation (GO:0070486) | 3.67955560 |
| 115 | carboxylic acid catabolic process (GO:0046395) | 3.66153531 |
| 116 | organic acid catabolic process (GO:0016054) | 3.66153531 |
| 117 | intestinal cholesterol absorption (GO:0030299) | 3.63993311 |
| 118 | protein activation cascade (GO:0072376) | 3.63863972 |
| 119 | complement activation (GO:0006956) | 3.63463334 |
| 120 | glucuronate metabolic process (GO:0019585) | 3.63237649 |
| 121 | uronic acid metabolic process (GO:0006063) | 3.63237649 |
| 122 | short-chain fatty acid metabolic process (GO:0046459) | 3.62672939 |
| 123 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.60858399 |
| 124 | oxygen transport (GO:0015671) | 3.60576370 |
| 125 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.55534095 |
| 126 | detection of external biotic stimulus (GO:0098581) | 3.51177930 |
| 127 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.48875853 |
| 128 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47682331 |
| 129 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.44904205 |
| 130 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.42263791 |
| 131 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.42263791 |
| 132 | negative regulation of phagocytosis (GO:0050765) | 3.33184032 |
| 133 | mannose metabolic process (GO:0006013) | 3.29222721 |
| 134 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.27781784 |
| 135 | neutrophil mediated immunity (GO:0002446) | 3.27344732 |
| 136 | microglial cell activation (GO:0001774) | 3.25210959 |
| 137 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.24609432 |
| 138 | neutrophil activation (GO:0042119) | 3.20167466 |
| 139 | response to muramyl dipeptide (GO:0032495) | 3.17639794 |
| 140 | regulation of mast cell degranulation (GO:0043304) | 3.17096100 |
| 141 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.14585273 |
| 142 | hemoglobin metabolic process (GO:0020027) | 3.14507268 |
| 143 | positive thymic T cell selection (GO:0045059) | 3.13992160 |
| 144 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.13608506 |
| 145 | germinal center formation (GO:0002467) | 3.13336233 |
| 146 | positive regulation of B cell differentiation (GO:0045579) | 3.13067860 |
| 147 | modulation by virus of host process (GO:0019054) | 3.12199151 |
| 148 | B cell receptor signaling pathway (GO:0050853) | 3.07212836 |
| 149 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.05438576 |
| 150 | macrophage activation (GO:0042116) | 3.05090996 |
| 151 | detection of biotic stimulus (GO:0009595) | 3.04036619 |
| 152 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.03549166 |
| 153 | respiratory burst (GO:0045730) | 3.03440743 |
| 154 | regulation of leukocyte degranulation (GO:0043300) | 3.01033423 |
| 155 | granulocyte activation (GO:0036230) | 3.00546835 |
| 156 | response to interleukin-15 (GO:0070672) | 2.98288920 |
| 157 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97627143 |
| 158 | positive regulation of granulocyte differentiation (GO:0030854) | 2.94897085 |
| 159 | myeloid cell activation involved in immune response (GO:0002275) | 2.93305885 |
| 160 | tolerance induction (GO:0002507) | 2.93277348 |
| 161 | negative regulation of interleukin-12 production (GO:0032695) | 2.93229982 |
| 162 | detection of molecule of bacterial origin (GO:0032490) | 2.92577045 |
| 163 | regulation of B cell differentiation (GO:0045577) | 2.92152882 |
| 164 | immunoglobulin mediated immune response (GO:0016064) | 2.91002039 |
| 165 | gas transport (GO:0015669) | 2.90532798 |
| 166 | erythrocyte maturation (GO:0043249) | 2.89442727 |
| 167 | modulation by symbiont of host cellular process (GO:0044068) | 2.88377235 |
| 168 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.86260854 |
| 169 | NIK/NF-kappaB signaling (GO:0038061) | 2.86069401 |
| 170 | negative thymic T cell selection (GO:0045060) | 2.85697872 |
| 171 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.85603805 |
| 172 | response to host immune response (GO:0052572) | 2.85603805 |
| 173 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.83788265 |
| 174 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.83074305 |
| 175 | cellular response to virus (GO:0098586) | 2.82621173 |
| 176 | thymic T cell selection (GO:0045061) | 2.79287256 |
| 177 | leukocyte degranulation (GO:0043299) | 2.75503073 |
| 178 | T cell selection (GO:0045058) | 2.71544579 |
| 179 | response to type I interferon (GO:0034340) | 2.71381922 |
| 180 | positive regulation of histone deacetylation (GO:0031065) | 2.71050915 |
| 181 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.71048484 |
| 182 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69888117 |
| 183 | response to host (GO:0075136) | 2.69888117 |
| 184 | response to host defenses (GO:0052200) | 2.69888117 |
| 185 | regulation of granulocyte differentiation (GO:0030852) | 2.69428798 |
| 186 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.69220651 |
| 187 | type I interferon signaling pathway (GO:0060337) | 2.68549373 |
| 188 | cellular response to type I interferon (GO:0071357) | 2.68549373 |
| 189 | megakaryocyte development (GO:0035855) | 2.67944128 |
| 190 | T cell migration (GO:0072678) | 2.66987379 |
| 191 | negative T cell selection (GO:0043383) | 2.66768703 |
| 192 | regulation of superoxide anion generation (GO:0032928) | 2.65624875 |
| 193 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.63004803 |
| 194 | regulation of ARF GTPase activity (GO:0032312) | 2.59003846 |
| 195 | negative regulation of interleukin-6 production (GO:0032715) | 2.58745158 |
| 196 | myeloid leukocyte mediated immunity (GO:0002444) | 2.58421313 |
| 197 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58257841 |
| 198 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.56599485 |
| 199 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.55563311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.36204969 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19919672 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.07723779 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.43531464 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24187447 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.13216215 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.52540184 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.99019208 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.95005030 |
| 10 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.60543259 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 3.14615925 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.59163004 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.48254817 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.45610250 |
| 15 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.45539051 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.36642839 |
| 17 | * MAF_26560356_Chip-Seq_TH1_Human | 2.28520902 |
| 18 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.27898691 |
| 19 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.22102990 |
| 20 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.17770299 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.15088869 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.08182818 |
| 23 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03947515 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9616793 |
| 25 | * MAF_26560356_Chip-Seq_TH2_Human | 1.98198196 |
| 26 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96517400 |
| 27 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.94133802 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.92047163 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90034176 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.83447247 |
| 31 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82623794 |
| 32 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80524903 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.78808531 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.77105555 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.75682900 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69670696 |
| 37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.68399019 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68241064 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.66611777 |
| 40 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65691477 |
| 41 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64598795 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59292071 |
| 43 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.59291666 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58604179 |
| 45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.57056339 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.55352922 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.55131579 |
| 48 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.54879635 |
| 49 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54454106 |
| 50 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.49473711 |
| 51 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.48710817 |
| 52 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.46471393 |
| 53 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.45799865 |
| 54 | MYB_26560356_Chip-Seq_TH2_Human | 1.44798365 |
| 55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41905582 |
| 56 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41376344 |
| 57 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40690391 |
| 58 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40585804 |
| 59 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40145555 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.38271075 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36852049 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34785892 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.33476195 |
| 64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.32087239 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30303991 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.27928879 |
| 67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26627693 |
| 68 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26016186 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24970723 |
| 70 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.22412498 |
| 71 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.21752602 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20273695 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18948641 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.18718615 |
| 75 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18302746 |
| 76 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17632560 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15877563 |
| 78 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.14078235 |
| 79 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11186815 |
| 80 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07921418 |
| 81 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07265398 |
| 82 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.06942432 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06893706 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03897619 |
| 85 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.02686743 |
| 86 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.02583951 |
| 87 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02327207 |
| 88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01827963 |
| 89 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00749988 |
| 90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00747299 |
| 91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.00299412 |
| 92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.97993658 |
| 93 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90283258 |
| 94 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.89682391 |
| 95 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.88364283 |
| 96 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.87741585 |
| 97 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82114327 |
| 98 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.81721701 |
| 99 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81654851 |
| 100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79845797 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75949635 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.75313313 |
| 103 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.74733394 |
| 104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74500330 |
| 105 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74293655 |
| 106 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.73828120 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70372567 |
| 108 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.69982221 |
| 109 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.69731824 |
| 110 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.69124258 |
| 111 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65712622 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.65555244 |
| 113 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.65102706 |
| 114 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64965008 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64480572 |
| 116 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.63523834 |
| 117 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61006097 |
| 118 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60414194 |
| 119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57827299 |
| 120 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.57645113 |
| 121 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.57558213 |
| 122 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57404089 |
| 123 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.56965129 |
| 124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56753883 |
| 125 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.56085167 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.53051287 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.52577606 |
| 128 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52480988 |
| 129 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.52300830 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.52214964 |
| 131 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.52131321 |
| 132 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.51974979 |
| 133 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.51533021 |
| 134 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50923897 |
| 135 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.50289378 |
| 136 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.49859888 |
| 137 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.49830266 |
| 138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.49431387 |
| 139 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 0.49044102 |
| 140 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.48688136 |
| 141 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47134783 |
| 142 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.46899195 |
| 143 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45903465 |
| 144 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.45254555 |
| 145 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45246027 |
| 146 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45238520 |
| 147 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.44957861 |
| 148 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44799641 |
| 149 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.44739407 |
| 150 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44391594 |
| 151 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.44020883 |
| 152 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.43289810 |
| 153 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.42888376 |
| 154 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.42319275 |
| 155 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.41936393 |
| 156 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.41566458 |
| 157 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.41562616 |
| 158 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.40732415 |
| 159 | CBP_21632823_ChIP-Seq_H3396_Human | 0.40058045 |
| 160 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.39853217 |
| 161 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.39588096 |
| 162 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.39377121 |
| 163 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.39226412 |
| 164 | P300_27268052_Chip-Seq_Bcells_Human | 0.38140853 |
| 165 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.37776539 |
| 166 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.37176071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.25904982 |
| 2 | MP0005360_urolithiasis | 7.70317589 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.29649333 |
| 4 | MP0005365_abnormal_bile_salt | 6.05069835 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.30586141 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.18055007 |
| 7 | MP0003303_peritoneal_inflammation | 3.94037281 |
| 8 | MP0003252_abnormal_bile_duct | 3.87538594 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.56181061 |
| 10 | MP0009840_abnormal_foam_cell | 3.39547297 |
| 11 | MP0003172_abnormal_lysosome_physiology | 3.07072513 |
| 12 | MP0005083_abnormal_biliary_tract | 3.02582314 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.72696853 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.71542253 |
| 15 | MP0005332_abnormal_amino_acid | 2.67179008 |
| 16 | MP0003195_calcinosis | 2.64016462 |
| 17 | MP0008260_abnormal_autophagy | 2.38718690 |
| 18 | MP0001800_abnormal_humoral_immune | 2.35121405 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.31710465 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.31651654 |
| 21 | MP0001790_abnormal_immune_system | 2.27444462 |
| 22 | MP0005387_immune_system_phenotype | 2.27444462 |
| 23 | MP0000609_abnormal_liver_physiology | 2.19509240 |
| 24 | MP0009278_abnormal_bone_marrow | 2.16814244 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.12233145 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.10496687 |
| 27 | MP0004019_abnormal_vitamin_homeostasis | 2.09404278 |
| 28 | MP0002723_abnormal_immune_serum | 2.08632108 |
| 29 | MP0001819_abnormal_immune_cell | 2.07382514 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 2.06161358 |
| 31 | MP0005671_abnormal_response_to | 1.96728338 |
| 32 | MP0009333_abnormal_splenocyte_physiolog | 1.95922437 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.93931559 |
| 34 | MP0002405_respiratory_system_inflammati | 1.93346778 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.93342994 |
| 36 | MP0003868_abnormal_feces_composition | 1.92569131 |
| 37 | MP0002138_abnormal_hepatobiliary_system | 1.92086265 |
| 38 | MP0002398_abnormal_bone_marrow | 1.88047590 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.87530760 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.87530760 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.87013117 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.83364865 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.78329540 |
| 44 | MP0001764_abnormal_homeostasis | 1.67228592 |
| 45 | MP0000716_abnormal_immune_system | 1.66906549 |
| 46 | MP0010155_abnormal_intestine_physiology | 1.63158744 |
| 47 | MP0009697_abnormal_copulation | 1.61015480 |
| 48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58555892 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.57375964 |
| 50 | MP0002722_abnormal_immune_system | 1.57358914 |
| 51 | MP0000689_abnormal_spleen_morphology | 1.55130872 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.54926527 |
| 53 | MP0002429_abnormal_blood_cell | 1.47605221 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.43877909 |
| 55 | MP0001873_stomach_inflammation | 1.39751464 |
| 56 | MP0003866_abnormal_defecation | 1.39638390 |
| 57 | MP0003011_delayed_dark_adaptation | 1.38369847 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.36098627 |
| 59 | MP0005451_abnormal_body_composition | 1.35768420 |
| 60 | MP0009643_abnormal_urine_homeostasis | 1.25298957 |
| 61 | MP0004510_myositis | 1.24925516 |
| 62 | MP0005310_abnormal_salivary_gland | 1.22223340 |
| 63 | MP0003186_abnormal_redox_activity | 1.22111991 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.21458456 |
| 65 | MP0000598_abnormal_liver_morphology | 1.20825203 |
| 66 | MP0000858_altered_metastatic_potential | 1.18194577 |
| 67 | MP0003878_abnormal_ear_physiology | 1.16144570 |
| 68 | MP0005377_hearing/vestibular/ear_phenot | 1.16144570 |
| 69 | MP0009764_decreased_sensitivity_to | 1.15667214 |
| 70 | MP0001851_eye_inflammation | 1.11416057 |
| 71 | MP0003828_pulmonary_edema | 1.07397474 |
| 72 | MP0000015_abnormal_ear_pigmentation | 1.07294886 |
| 73 | MP0009763_increased_sensitivity_to | 1.06084656 |
| 74 | MP0000604_amyloidosis | 1.03993208 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 1.03487715 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 1.01483933 |
| 77 | MP0005647_abnormal_sex_gland | 1.00079654 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 0.99929983 |
| 79 | MP0008469_abnormal_protein_level | 0.98853845 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.98007986 |
| 81 | MP0003123_paternal_imprinting | 0.97780611 |
| 82 | MP0002998_abnormal_bone_remodeling | 0.97670885 |
| 83 | MP0002933_joint_inflammation | 0.93825183 |
| 84 | MP0009642_abnormal_blood_homeostasis | 0.89826202 |
| 85 | MP0001663_abnormal_digestive_system | 0.88875528 |
| 86 | MP0009765_abnormal_xenobiotic_induced | 0.88133527 |
| 87 | MP0001986_abnormal_taste_sensitivity | 0.87151061 |
| 88 | MP0002254_reproductive_system_inflammat | 0.86266381 |
| 89 | MP0006036_abnormal_mitochondrial_physio | 0.83522687 |
| 90 | MP0005084_abnormal_gallbladder_morpholo | 0.79834036 |
| 91 | MP0010368_abnormal_lymphatic_system | 0.78777699 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.78611664 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.77706716 |
| 94 | MP0005164_abnormal_response_to | 0.77633100 |
| 95 | MP0005464_abnormal_platelet_physiology | 0.74734933 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.74453192 |
| 97 | MP0005408_hypopigmentation | 0.72004410 |
| 98 | MP0002166_altered_tumor_susceptibility | 0.71860487 |
| 99 | MP0005334_abnormal_fat_pad | 0.70877956 |
| 100 | MP0002971_abnormal_brown_adipose | 0.70429736 |
| 101 | MP0000465_gastrointestinal_hemorrhage | 0.70336980 |
| 102 | MP0003045_fibrosis | 0.69232552 |
| 103 | MP0005535_abnormal_body_temperature | 0.68826624 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.68757310 |
| 105 | MP0003436_decreased_susceptibility_to | 0.68585078 |
| 106 | MP0003879_abnormal_hair_cell | 0.68485305 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.68262845 |
| 108 | MP0005670_abnormal_white_adipose | 0.68252977 |
| 109 | MP0000490_abnormal_crypts_of | 0.68164207 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.67046571 |
| 111 | MP0000343_altered_response_to | 0.64491130 |
| 112 | MP0005266_abnormal_metabolism | 0.64245514 |
| 113 | MP0002876_abnormal_thyroid_physiology | 0.63114085 |
| 114 | MP0002822_catalepsy | 0.62556200 |
| 115 | MP0003690_abnormal_glial_cell | 0.59232468 |
| 116 | MP0005448_abnormal_energy_balance | 0.57834994 |
| 117 | MP0003724_increased_susceptibility_to | 0.56805443 |
| 118 | MP0003329_amyloid_beta_deposits | 0.56438282 |
| 119 | MP0001756_abnormal_urination | 0.55839901 |
| 120 | MP0004130_abnormal_muscle_cell | 0.55747902 |
| 121 | MP0006035_abnormal_mitochondrial_morpho | 0.54714127 |
| 122 | MP0008874_decreased_physiological_sensi | 0.53472187 |
| 123 | MP0008873_increased_physiological_sensi | 0.52627656 |
| 124 | MP0008872_abnormal_physiological_respon | 0.52046616 |
| 125 | MP0000639_abnormal_adrenal_gland | 0.51046877 |
| 126 | MP0009053_abnormal_anal_canal | 0.50647161 |
| 127 | MP0001661_extended_life_span | 0.50550075 |
| 128 | MP0002928_abnormal_bile_duct | 0.49454584 |
| 129 | MP0004147_increased_porphyrin_level | 0.49436904 |
| 130 | MP0006082_CNS_inflammation | 0.48554696 |
| 131 | MP0003638_abnormal_response/metabolism_ | 0.47904852 |
| 132 | MP0002136_abnormal_kidney_physiology | 0.46774889 |
| 133 | MP0001853_heart_inflammation | 0.45460655 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.44634505 |
| 135 | MP0003075_altered_response_to | 0.43647492 |
| 136 | MP0001845_abnormal_inflammatory_respons | 0.42108269 |
| 137 | MP0003953_abnormal_hormone_level | 0.39762303 |
| 138 | MP0005166_decreased_susceptibility_to | 0.39468431 |
| 139 | MP0009115_abnormal_fat_cell | 0.38442220 |
| 140 | MP0005395_other_phenotype | 0.37639714 |
| 141 | MP0004381_abnormal_hair_follicle | 0.37471672 |
| 142 | MP0002132_abnormal_respiratory_system | 0.36796248 |
| 143 | MP0002970_abnormal_white_adipose | 0.35837291 |
| 144 | MP0003718_maternal_effect | 0.35598838 |
| 145 | MP0009672_abnormal_birth_weight | 0.35241013 |
| 146 | MP0000249_abnormal_blood_vessel | 0.33392949 |
| 147 | MP0004947_skin_inflammation | 0.29908076 |
| 148 | MP0005025_abnormal_response_to | 0.29068208 |
| 149 | MP0001243_abnormal_dermal_layer | 0.28853788 |
| 150 | MP0005248_abnormal_Harderian_gland | 0.28671687 |
| 151 | MP0004883_abnormal_blood_vessel | 0.27671906 |
| 152 | MP0009785_altered_susceptibility_to | 0.27564729 |
| 153 | MP0002837_dystrophic_cardiac_calcinosis | 0.26663308 |
| 154 | MP0005666_abnormal_adipose_tissue | 0.25717101 |
| 155 | MP0004264_abnormal_extraembryonic_tissu | 0.25660645 |
| 156 | MP0002419_abnormal_innate_immunity | 0.23567538 |
| 157 | MP0000685_abnormal_immune_system | 0.23387434 |
| 158 | MP0005058_abnormal_lysosome_morphology | 0.23205475 |
| 159 | MP0001944_abnormal_pancreas_morphology | 0.22330828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.51317908 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.22092066 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.05090364 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.58010250 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.50588649 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.49432876 |
| 7 | Xanthomatosis (HP:0000991) | 6.12153683 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.55990258 |
| 9 | Complement deficiency (HP:0004431) | 5.13174840 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.86692695 |
| 11 | Joint hemorrhage (HP:0005261) | 4.82358029 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.74005908 |
| 13 | Hypochromic anemia (HP:0001931) | 4.54801987 |
| 14 | Hyperammonemia (HP:0001987) | 4.47173952 |
| 15 | Recurrent abscess formation (HP:0002722) | 4.34164458 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.31738836 |
| 17 | Ketosis (HP:0001946) | 4.30008626 |
| 18 | Abnormality of the common coagulation pathway (HP:0010990) | 4.29493968 |
| 19 | Hyperglycinemia (HP:0002154) | 4.27445579 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.24382741 |
| 21 | Epidermoid cyst (HP:0200040) | 4.23718615 |
| 22 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.18497849 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17689086 |
| 24 | Recurrent bacterial skin infections (HP:0005406) | 4.13928312 |
| 25 | Abnormality of macrophages (HP:0004311) | 4.13491728 |
| 26 | Abnormality of methionine metabolism (HP:0010901) | 4.08171656 |
| 27 | Myositis (HP:0100614) | 4.06863004 |
| 28 | Fat malabsorption (HP:0002630) | 4.02657344 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 4.02146015 |
| 30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.96558371 |
| 31 | Prolonged bleeding time (HP:0003010) | 3.95449769 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91938325 |
| 33 | Hyperglycinuria (HP:0003108) | 3.85454688 |
| 34 | Abnormality of glycine metabolism (HP:0010895) | 3.84607627 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.84607627 |
| 36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.81103677 |
| 37 | Obstructive lung disease (HP:0006536) | 3.81103677 |
| 38 | Hypoglycemic coma (HP:0001325) | 3.72909183 |
| 39 | Abnormality of complement system (HP:0005339) | 3.72636838 |
| 40 | Conjugated hyperbilirubinemia (HP:0002908) | 3.70626665 |
| 41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70330424 |
| 42 | Hyperbilirubinemia (HP:0002904) | 3.63039289 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.58289681 |
| 44 | Orchitis (HP:0100796) | 3.47044527 |
| 45 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.44768553 |
| 46 | Hypochromic microcytic anemia (HP:0004840) | 3.43621021 |
| 47 | Gastrointestinal infarctions (HP:0005244) | 3.42820307 |
| 48 | Stomatitis (HP:0010280) | 3.39743734 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.35096095 |
| 50 | Meningitis (HP:0001287) | 3.32240546 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26975383 |
| 52 | Recurrent fungal infections (HP:0002841) | 3.26590378 |
| 53 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.19548504 |
| 54 | Microcytic anemia (HP:0001935) | 3.16397826 |
| 55 | Epistaxis (HP:0000421) | 3.16157322 |
| 56 | Retrobulbar optic neuritis (HP:0100654) | 3.15221405 |
| 57 | Optic neuritis (HP:0100653) | 3.15221405 |
| 58 | Abnormality of nucleobase metabolism (HP:0010932) | 3.14451711 |
| 59 | Mediastinal lymphadenopathy (HP:0100721) | 3.09107596 |
| 60 | Increased IgE level (HP:0003212) | 3.07670395 |
| 61 | Acanthocytosis (HP:0001927) | 3.05356977 |
| 62 | Recurrent skin infections (HP:0001581) | 3.03741160 |
| 63 | Delayed CNS myelination (HP:0002188) | 3.02781503 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 3.00295095 |
| 65 | Steatorrhea (HP:0002570) | 2.99419373 |
| 66 | Ketoacidosis (HP:0001993) | 2.92320311 |
| 67 | Myocardial infarction (HP:0001658) | 2.91353241 |
| 68 | Pustule (HP:0200039) | 2.90888891 |
| 69 | Spontaneous abortion (HP:0005268) | 2.90487288 |
| 70 | Cellulitis (HP:0100658) | 2.89814886 |
| 71 | Abnormality of serum amino acid levels (HP:0003112) | 2.85899408 |
| 72 | Polycythemia (HP:0001901) | 2.83359276 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.82196763 |
| 74 | Metabolic acidosis (HP:0001942) | 2.79622708 |
| 75 | Poikilocytosis (HP:0004447) | 2.77680143 |
| 76 | Petechiae (HP:0000967) | 2.77582802 |
| 77 | Purpura (HP:0000979) | 2.77530726 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.75708405 |
| 79 | Inflammation of the large intestine (HP:0002037) | 2.73480853 |
| 80 | Systemic lupus erythematosus (HP:0002725) | 2.72742612 |
| 81 | Urticaria (HP:0001025) | 2.71262980 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 2.69798328 |
| 83 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.69798328 |
| 84 | Gingivitis (HP:0000230) | 2.69539402 |
| 85 | Vasculitis (HP:0002633) | 2.68018603 |
| 86 | Abnormal gallbladder morphology (HP:0012437) | 2.67835596 |
| 87 | Slow saccadic eye movements (HP:0000514) | 2.66324795 |
| 88 | Encephalitis (HP:0002383) | 2.65804642 |
| 89 | Spontaneous hematomas (HP:0007420) | 2.65752851 |
| 90 | Cholelithiasis (HP:0001081) | 2.63842394 |
| 91 | Skin nodule (HP:0200036) | 2.61861993 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.49458833 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.49458833 |
| 94 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.49458833 |
| 95 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49356408 |
| 96 | Vascular calcification (HP:0004934) | 2.48217438 |
| 97 | Panhypogammaglobulinemia (HP:0003139) | 2.47733382 |
| 98 | Colitis (HP:0002583) | 2.46789235 |
| 99 | Lethargy (HP:0001254) | 2.46345096 |
| 100 | Dicarboxylic aciduria (HP:0003215) | 2.45692672 |
| 101 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.45692672 |
| 102 | Keratoconjunctivitis sicca (HP:0001097) | 2.45626483 |
| 103 | Hypoglycemic seizures (HP:0002173) | 2.43865332 |
| 104 | Recurrent viral infections (HP:0004429) | 2.43043902 |
| 105 | Dysostosis multiplex (HP:0000943) | 2.43030803 |
| 106 | Cholecystitis (HP:0001082) | 2.40565201 |
| 107 | Abnormal gallbladder physiology (HP:0012438) | 2.40565201 |
| 108 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.39687294 |
| 109 | Spastic diplegia (HP:0001264) | 2.39043651 |
| 110 | Mitral stenosis (HP:0001718) | 2.38296681 |
| 111 | Episodic fever (HP:0001954) | 2.37243909 |
| 112 | Gingival bleeding (HP:0000225) | 2.36110700 |
| 113 | Gout (HP:0001997) | 2.35378781 |
| 114 | Amyloidosis (HP:0011034) | 2.34204182 |
| 115 | Irritability (HP:0000737) | 2.32457952 |
| 116 | Mucopolysacchariduria (HP:0008155) | 2.32447021 |
| 117 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.32447021 |
| 118 | Granulocytopenia (HP:0001913) | 2.31353765 |
| 119 | Chest pain (HP:0100749) | 2.31329434 |
| 120 | Malnutrition (HP:0004395) | 2.30226370 |
| 121 | Neonatal onset (HP:0003623) | 2.29714831 |
| 122 | Glomerulonephritis (HP:0000099) | 2.28084975 |
| 123 | Cerebral edema (HP:0002181) | 2.24900218 |
| 124 | Abnormality of the fingertips (HP:0001211) | 2.24718617 |
| 125 | Increased cerebral lipofuscin (HP:0011813) | 2.24220422 |
| 126 | Anorexia (HP:0002039) | 2.23348418 |
| 127 | Menorrhagia (HP:0000132) | 2.23285109 |
| 128 | Keratoconjunctivitis (HP:0001096) | 2.22543762 |
| 129 | Late onset (HP:0003584) | 2.18486360 |
| 130 | Reticulocytosis (HP:0001923) | 2.16637179 |
| 131 | Thrombophlebitis (HP:0004418) | 2.15724431 |
| 132 | Abnormality of the gallbladder (HP:0005264) | 2.15419199 |
| 133 | Cardiovascular calcification (HP:0011915) | 2.15144385 |
| 134 | Brushfield spots (HP:0001088) | 2.15097768 |
| 135 | Hypertriglyceridemia (HP:0002155) | 2.13718562 |
| 136 | Pancreatitis (HP:0001733) | 2.12846161 |
| 137 | Sensorimotor neuropathy (HP:0007141) | 2.12752275 |
| 138 | Abnormal platelet function (HP:0011869) | 2.11962098 |
| 139 | Impaired platelet aggregation (HP:0003540) | 2.11962098 |
| 140 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.11193399 |
| 141 | Hypertensive crisis (HP:0100735) | 2.10199612 |
| 142 | Enlarged kidneys (HP:0000105) | 2.10127852 |
| 143 | Hemorrhage of the eye (HP:0011885) | 2.09395653 |
| 144 | Abnormal platelet volume (HP:0011876) | 2.09206359 |
| 145 | Esophageal varix (HP:0002040) | 2.08781807 |
| 146 | Pulmonary infiltrates (HP:0002113) | 2.08752121 |
| 147 | Vomiting (HP:0002013) | 2.05955435 |
| 148 | Abnormality of iron homeostasis (HP:0011031) | 2.05942340 |
| 149 | Hemoptysis (HP:0002105) | 2.04497969 |
| 150 | Generalized aminoaciduria (HP:0002909) | 2.02485859 |
| 151 | Osteomyelitis (HP:0002754) | 2.00922113 |
| 152 | Loss of speech (HP:0002371) | 2.00222781 |
| 153 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99965118 |
| 154 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.98938511 |
| 155 | Polygenic inheritance (HP:0010982) | 1.98529502 |
| 156 | Arterial thrombosis (HP:0004420) | 1.98371688 |
| 157 | Abnormality of T cell physiology (HP:0011840) | 1.97883808 |
| 158 | Abnormal hemoglobin (HP:0011902) | 1.97876085 |
| 159 | Increased IgM level (HP:0003496) | 1.96400781 |
| 160 | Opisthotonus (HP:0002179) | 1.95385875 |
| 161 | Thrombocytosis (HP:0001894) | 1.95159470 |
| 162 | Acne (HP:0001061) | 1.94762039 |
| 163 | Agammaglobulinemia (HP:0004432) | 1.92940635 |
| 164 | Rickets (HP:0002748) | 1.92505206 |
| 165 | Hydroxyprolinuria (HP:0003080) | 1.91788745 |
| 166 | Abnormality of proline metabolism (HP:0010907) | 1.91788745 |
| 167 | Leukocytosis (HP:0001974) | 1.91575045 |
| 168 | Hypergammaglobulinemia (HP:0010702) | 1.91054082 |
| 169 | Viral hepatitis (HP:0006562) | 1.90569176 |
| 170 | Status epilepticus (HP:0002133) | 1.88996896 |
| 171 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88283270 |
| 172 | Elevated hepatic transaminases (HP:0002910) | 1.87643277 |
| 173 | Lymphopenia (HP:0001888) | 1.85239599 |
| 174 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83182033 |
| 175 | Renal cortical cysts (HP:0000803) | 1.82457085 |
| 176 | Abnormal cartilage morphology (HP:0002763) | 1.76422706 |
| 177 | Pulmonary embolism (HP:0002204) | 1.76256809 |
| 178 | Hypophosphatemic rickets (HP:0004912) | 1.75894836 |
| 179 | Alkalosis (HP:0001948) | 1.74260223 |
| 180 | Increased serum ferritin (HP:0003281) | 1.69646561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.73398332 |
| 2 | ERN1 | 4.56206496 |
| 3 | FGFR4 | 4.43318851 |
| 4 | SIK1 | 4.30178535 |
| 5 | TAOK3 | 3.50955057 |
| 6 | RIPK4 | 3.46400714 |
| 7 | INSRR | 3.17616302 |
| 8 | PRPF4B | 2.94539030 |
| 9 | TNK2 | 2.57262449 |
| 10 | IRAK4 | 2.49692838 |
| 11 | TAOK1 | 2.45390855 |
| 12 | ERBB4 | 2.17663911 |
| 13 | PKN2 | 2.09995415 |
| 14 | MAP2K4 | 2.07269290 |
| 15 | GRK6 | 1.99602521 |
| 16 | MAPK11 | 1.96504368 |
| 17 | SMG1 | 1.93884083 |
| 18 | TYK2 | 1.89279116 |
| 19 | MAP3K10 | 1.88798505 |
| 20 | FLT3 | 1.75754242 |
| 21 | TBK1 | 1.58759801 |
| 22 | TRIB3 | 1.57647439 |
| 23 | FES | 1.56870942 |
| 24 | PTK6 | 1.56684738 |
| 25 | PIK3CG | 1.50544687 |
| 26 | DAPK2 | 1.49848300 |
| 27 | MST1R | 1.48695056 |
| 28 | SIK3 | 1.47475945 |
| 29 | MAP4K1 | 1.41410798 |
| 30 | MARK2 | 1.40701657 |
| 31 | ABL2 | 1.34114529 |
| 32 | MAP3K14 | 1.33837618 |
| 33 | CDK12 | 1.30706415 |
| 34 | JAK2 | 1.29973303 |
| 35 | HCK | 1.22395682 |
| 36 | IRAK2 | 1.20246878 |
| 37 | MAP3K7 | 1.19356273 |
| 38 | PRKD2 | 1.15889954 |
| 39 | FGR | 1.14469017 |
| 40 | PRKAA2 | 1.14433789 |
| 41 | MAP2K3 | 1.13337682 |
| 42 | EEF2K | 1.11861591 |
| 43 | KSR2 | 1.10714338 |
| 44 | JAK1 | 1.09395929 |
| 45 | DYRK1B | 1.09087231 |
| 46 | IRAK3 | 1.07657475 |
| 47 | KDR | 1.06815987 |
| 48 | IKBKE | 1.06444292 |
| 49 | MAPK4 | 1.06156548 |
| 50 | ERBB2 | 1.05493063 |
| 51 | EPHB1 | 1.05425172 |
| 52 | FRK | 1.02153001 |
| 53 | MAP3K11 | 1.01766481 |
| 54 | MAPK15 | 0.99229226 |
| 55 | CDC42BPA | 0.97852671 |
| 56 | HIPK2 | 0.96975149 |
| 57 | MAPK12 | 0.96809239 |
| 58 | NEK9 | 0.95358216 |
| 59 | CDK6 | 0.95067244 |
| 60 | CSK | 0.91509910 |
| 61 | BMX | 0.86945174 |
| 62 | PINK1 | 0.85392228 |
| 63 | CAMK1D | 0.84899815 |
| 64 | MARK3 | 0.83704813 |
| 65 | TGFBR2 | 0.82885031 |
| 66 | LCK | 0.81798025 |
| 67 | PRKCZ | 0.77129816 |
| 68 | SGK3 | 0.76476178 |
| 69 | FGFR2 | 0.75563994 |
| 70 | CSF1R | 0.75239478 |
| 71 | LATS1 | 0.72530161 |
| 72 | MATK | 0.72009350 |
| 73 | PRKACG | 0.71980847 |
| 74 | MAP3K3 | 0.71214963 |
| 75 | PRKAA1 | 0.70825175 |
| 76 | IRAK1 | 0.70280579 |
| 77 | RIPK1 | 0.67417406 |
| 78 | PRKCQ | 0.65928254 |
| 79 | ICK | 0.64997942 |
| 80 | FGFR3 | 0.64429223 |
| 81 | MAP2K6 | 0.63597663 |
| 82 | CDK4 | 0.63542824 |
| 83 | TXK | 0.62879482 |
| 84 | MAP3K2 | 0.62714533 |
| 85 | RPS6KL1 | 0.61889265 |
| 86 | RPS6KC1 | 0.61889265 |
| 87 | SIK2 | 0.59463143 |
| 88 | TESK2 | 0.59258155 |
| 89 | PTK2B | 0.59240644 |
| 90 | GSK3A | 0.56330112 |
| 91 | MAP3K13 | 0.56329638 |
| 92 | MAPK7 | 0.54668406 |
| 93 | PKN1 | 0.52957415 |
| 94 | RPS6KA2 | 0.51902917 |
| 95 | RPS6KA6 | 0.49990083 |
| 96 | CAMK2G | 0.49861834 |
| 97 | BTK | 0.49395434 |
| 98 | PRKG2 | 0.48468747 |
| 99 | STK10 | 0.48381380 |
| 100 | PDPK1 | 0.48349458 |
| 101 | CAMK1G | 0.47201029 |
| 102 | MAP3K8 | 0.46239530 |
| 103 | SGK2 | 0.45837014 |
| 104 | MAP3K5 | 0.45797425 |
| 105 | GRK1 | 0.45382859 |
| 106 | CAMK4 | 0.44974279 |
| 107 | EPHA3 | 0.43881055 |
| 108 | IKBKB | 0.43077085 |
| 109 | PTK2 | 0.42679529 |
| 110 | CSNK1G1 | 0.40917583 |
| 111 | STK11 | 0.39859527 |
| 112 | ITK | 0.39817942 |
| 113 | STK38 | 0.39465467 |
| 114 | PDK1 | 0.39323260 |
| 115 | MAP3K1 | 0.39150350 |
| 116 | TIE1 | 0.39097649 |
| 117 | JAK3 | 0.39064642 |
| 118 | ZAP70 | 0.38531487 |
| 119 | MAPKAPK2 | 0.38225227 |
| 120 | MTOR | 0.37824281 |
| 121 | CHUK | 0.37506987 |
| 122 | FYN | 0.37309481 |
| 123 | SYK | 0.37171610 |
| 124 | KIT | 0.37009822 |
| 125 | MAP3K6 | 0.36765772 |
| 126 | RPS6KA1 | 0.36696644 |
| 127 | EGFR | 0.36606698 |
| 128 | MAP2K2 | 0.36559635 |
| 129 | CAMKK1 | 0.33966892 |
| 130 | TEC | 0.32545249 |
| 131 | YES1 | 0.32525266 |
| 132 | RET | 0.32282528 |
| 133 | IGF1R | 0.30964596 |
| 134 | SGK494 | 0.30711530 |
| 135 | SGK223 | 0.30711530 |
| 136 | PRKCH | 0.30118290 |
| 137 | LYN | 0.30031950 |
| 138 | STK4 | 0.28929748 |
| 139 | TAOK2 | 0.26789642 |
| 140 | CSNK1G3 | 0.25917781 |
| 141 | CSNK1G2 | 0.24538799 |
| 142 | ABL1 | 0.24375500 |
| 143 | MAPK3 | 0.24218402 |
| 144 | BLK | 0.23512583 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.50007740 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.42011829 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.37459211 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.34299492 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04205542 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.92010531 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.79694457 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.71878039 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.71717644 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57679682 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.56647218 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.54639479 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.53868152 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.49571526 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41885293 |
| 16 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31097588 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.29928763 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29803421 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23469980 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.18552481 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.05001225 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03514646 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.00055368 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.98220165 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.96358392 |
| 26 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95741915 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95630344 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.95180413 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.92315923 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.84524776 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82401486 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79755939 |
| 33 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.79425957 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.78532004 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.77475954 |
| 36 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.76524663 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.74130686 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.72150016 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.71732676 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.69812829 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.69636046 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.68545110 |
| 43 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63886753 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62134970 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.57979159 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.57911913 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 1.57709238 |
| 48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55943351 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.52586559 |
| 50 | Measles_Homo sapiens_hsa05162 | 1.48191948 |
| 51 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.48058960 |
| 52 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47067858 |
| 53 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45136843 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41692859 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41468153 |
| 56 | Allograft rejection_Homo sapiens_hsa05330 | 1.40022181 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 1.37907877 |
| 58 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37873198 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37258374 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34229414 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.33899486 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.33292614 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32288273 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31856054 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31680045 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 1.28667012 |
| 67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.28023853 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.26867527 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.26335866 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25786994 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.25399991 |
| 72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.23976418 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.23779032 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.23710573 |
| 75 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23301748 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21786573 |
| 77 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18974140 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 1.17006624 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.15284245 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14390454 |
| 81 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14042802 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13187975 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13055943 |
| 84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.11485267 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 1.06960633 |
| 86 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05247516 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02031729 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.01581943 |
| 89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00883239 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 1.00494304 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.98873312 |
| 92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97915614 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.97543710 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.96595070 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96167109 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95553028 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95015215 |
| 98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.93666357 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91602083 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.90556484 |
| 101 | Lysosome_Homo sapiens_hsa04142 | 0.89281592 |
| 102 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.88999181 |
| 103 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87808385 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.87577224 |
| 105 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87529721 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85639190 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.85318125 |
| 108 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85206517 |
| 109 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81467651 |
| 110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.80851446 |
| 111 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.78213569 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76222209 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75280046 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.68339989 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.67823125 |
| 116 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67175383 |
| 117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.67156763 |
| 118 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66670157 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66555176 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.66330718 |
| 121 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65497563 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.65199691 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63922989 |
| 124 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63191420 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63167718 |
| 126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62683790 |
| 127 | Salmonella infection_Homo sapiens_hsa05132 | 0.61864389 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.60972269 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.59907686 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59266526 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.59069483 |
| 132 | Asthma_Homo sapiens_hsa05310 | 0.58913574 |
| 133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57559495 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55047164 |
| 135 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.54574670 |
| 136 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54458201 |
| 137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53992112 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52018168 |
| 139 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.51717300 |
| 140 | Amoebiasis_Homo sapiens_hsa05146 | 0.47756222 |
| 141 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47014146 |
| 142 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46934054 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45852168 |
| 144 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.45481167 |
| 145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44408592 |
| 146 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34584206 |
| 147 | Prion diseases_Homo sapiens_hsa05020 | 0.33882063 |
| 148 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.33566462 |
| 149 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26421254 |
| 150 | Insulin resistance_Homo sapiens_hsa04931 | 0.24882117 |
| 151 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24550547 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.23862747 |
| 153 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19613028 |
| 154 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17064552 |
| 155 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.10966906 |
| 156 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06942221 |
| 157 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.02833080 |
| 158 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01591705 |
| 159 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2338551 |
| 160 | Pertussis_Homo sapiens_hsa05133 | -0.2330356 |
| 161 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2310423 |
| 162 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.2170062 |
| 163 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2074093 |
| 164 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2004391 |
| 165 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1960213 |
| 166 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1854545 |
| 167 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1526769 |
| 168 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1443767 |
| 169 | Hepatitis C_Homo sapiens_hsa05160 | -0.1313894 |
| 170 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1145450 |
| 171 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.1112826 |
| 172 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1081320 |
| 173 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1019621 |
| 174 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0892997 |
| 175 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0868076 |
| 176 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0824723 |
| 177 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0800522 |
| 178 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0691938 |

